Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 49 adverse event reports in the FDA FAERS database where IBRUTINIB was used for Prostate cancer.

Most Reported Side Effects for IBRUTINIB

Side Effect Reports % Deaths Hosp.
Death 8,007 10.7% 7,998 836
Off label use 5,446 7.3% 866 1,760
Fatigue 4,479 6.0% 203 1,352
Diarrhoea 3,903 5.2% 331 1,322
Atrial fibrillation 3,671 4.9% 407 1,633
Pneumonia 3,015 4.0% 679 2,279
Incorrect dose administered 2,752 3.7% 250 887
Contusion 2,712 3.6% 102 770
Fall 2,375 3.2% 243 1,444
Asthenia 2,200 2.9% 191 1,104
Nausea 2,142 2.9% 146 764
Arthralgia 2,095 2.8% 99 503
Rash 2,029 2.7% 93 487
Haemorrhage 1,907 2.5% 183 461
Disease progression 1,813 2.4% 676 584

Other Indications for IBRUTINIB

Chronic lymphocytic leukaemia (37,003) Product used for unknown indication (15,132) Mantle cell lymphoma (6,306) Waldenstrom's macroglobulinaemia (5,044) B-cell small lymphocytic lymphoma (1,882) Non-hodgkin's lymphoma (1,581) Diffuse large b-cell lymphoma (1,382) Lymphocytic leukaemia (1,308) B-cell lymphoma (933) Lymphoma (896)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

IBRUTINIB Full Profile All Prostate cancer Drugs IBRUTINIB Demographics IBRUTINIB Timeline